$CGC
Canopy Growth Corp

2024 Q4 Form 10-Q Financial Statement

#000095017024123672 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $62.99M
YoY Change -9.49%
Cost Of Revenue $41.15M
YoY Change -10.86%
Gross Profit $21.84M
YoY Change -6.78%
Gross Profit Margin 34.67%
Selling, General & Admin $41.73M
YoY Change -27.57%
% of Gross Profit 191.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $67.78M
YoY Change 122.72%
Operating Profit -$45.94M
YoY Change 555.67%
Interest Expense $21.28M
YoY Change -22.39%
% of Operating Profit
Other Income/Expense, Net -$85.31M
YoY Change -33.53%
Pretax Income -$131.2M
YoY Change -3.02%
Income Tax $302.0K
% Of Pretax Income
Net Earnings -$128.3M
YoY Change -58.62%
Net Earnings / Revenue -203.67%
Basic Earnings Per Share -$1.48
Diluted Earnings Per Share -$1.48
COMMON SHARES
Basic Shares Outstanding 105.4M 84.86M
Diluted Shares Outstanding 86.83M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $228.4M
Short-Term Investments
Other Short-Term Assets $4.351M
YoY Change -37.11%
Inventory $90.09M
Prepaid Expenses $11.94M
Receivables $36.52M
Other Receivables $1.377M
Total Short-Term Assets $391.7M
YoY Change -20.67%
LONG-TERM ASSETS
Property, Plant & Equipment $303.2M
YoY Change -12.44%
Goodwill $44.53M
YoY Change -46.9%
Intangibles $95.39M
YoY Change -35.88%
Long-Term Investments $136.4M
YoY Change -75.49%
Other Assets $19.08M
YoY Change 0.64%
Total Long-Term Assets $840.7M
YoY Change -28.42%
TOTAL ASSETS
Total Short-Term Assets $391.7M
Total Long-Term Assets $840.7M
Total Assets $1.232B
YoY Change -26.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.36M
YoY Change -19.19%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $137.9M
YoY Change 176.03%
Total Short-Term Liabilities $281.3M
YoY Change 43.33%
LONG-TERM LIABILITIES
Long-Term Debt $415.9M
YoY Change -34.11%
Other Long-Term Liabilities $25.46M
YoY Change -71.49%
Total Long-Term Liabilities $441.4M
YoY Change -38.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $281.3M
Total Long-Term Liabilities $441.4M
Total Liabilities $722.7M
YoY Change -21.34%
SHAREHOLDERS EQUITY
Retained Earnings -$10.59B
YoY Change 5.63%
Common Stock $11.11B
YoY Change 2.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $509.7M
YoY Change
Total Liabilities & Shareholders Equity $1.232B
YoY Change -26.13%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$128.3M
YoY Change -58.62%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001737927
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q3 us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.canopygrowth.com/20240930#ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.canopygrowth.com/20240930#ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
CY2023Q3 us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.canopygrowth.com/20240930#ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.canopygrowth.com/20240930#ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38496
dei Entity Registrant Name
EntityRegistrantName
Canopy Growth Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
1 Hershey Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Smiths Falls
dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
K7A 0A8
dei City Area Code
CityAreaCode
855
dei Local Phone Number
LocalPhoneNumber
558-9333
dei Security12b Title
Security12bTitle
Common shares, no par value
dei Trading Symbol
TradingSymbol
CGC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
105360224
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228416000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170300000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
2805000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
33161000
CY2024Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
7490000
CY2024Q1 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
7310000
CY2024Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
41860000
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
51847000
CY2024Q3 us-gaap Inventory Net
InventoryNet
90094000
CY2024Q1 us-gaap Inventory Net
InventoryNet
77292000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
8038000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21000000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23232000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
391665000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
371180000
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
136377000
CY2024Q3 cgc Other Financial Assets
OtherFinancialAssets
242145000
CY2024Q1 cgc Other Financial Assets
OtherFinancialAssets
437629000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303165000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320103000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95386000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
104053000
CY2024Q3 us-gaap Goodwill
Goodwill
44531000
CY2024Q1 us-gaap Goodwill
Goodwill
43239000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19079000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24126000
CY2024Q3 us-gaap Assets
Assets
1232348000
CY2024Q1 us-gaap Assets
Assets
1300330000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
18364000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
28673000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
42736000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
54039000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
137918000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
103935000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
82266000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48068000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
281284000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
234715000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
415932000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
493294000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25464000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
71814000
CY2024Q3 us-gaap Liabilities
Liabilities
722680000
CY2024Q1 us-gaap Liabilities
Liabilities
799823000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
93863960
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
93863960
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91115501
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91115501
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
8490670000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
8244301000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2620491000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2602148000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16032000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16051000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10585461000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10330030000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
509668000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
500368000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
139000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
509668000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
500507000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1232348000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1300330000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
73958000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
82076000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
149741000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
170720000
CY2024Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
10967000
CY2023Q3 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
12481000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
20538000
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
24867000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62991000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69595000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129203000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145853000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41153000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46169000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
84334000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108665000
CY2024Q3 us-gaap Gross Profit
GrossProfit
21838000
CY2023Q3 us-gaap Gross Profit
GrossProfit
23426000
us-gaap Gross Profit
GrossProfit
44869000
us-gaap Gross Profit
GrossProfit
37188000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41730000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57611000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89698000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120374000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5221000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2717000
us-gaap Share Based Compensation
ShareBasedCompensation
9372000
us-gaap Share Based Compensation
ShareBasedCompensation
6434000
CY2024Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20830000
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
29895000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20850000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
27961000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
67781000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
30433000
us-gaap Operating Expenses
OperatingExpenses
119920000
us-gaap Operating Expenses
OperatingExpenses
98847000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-45943000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7007000
us-gaap Operating Income Loss
OperatingIncomeLoss
-75051000
us-gaap Operating Income Loss
OperatingIncomeLoss
-61659000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-85305000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-128334000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-179194000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-82233000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-131248000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-135341000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-254245000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-143892000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
302000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12821000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6496000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14839000
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-131550000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-148162000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-260741000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-158731000
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
3257000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-176638000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
5310000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-207930000
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-128293000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-324800000
us-gaap Profit Loss
ProfitLoss
-255431000
us-gaap Profit Loss
ProfitLoss
-366661000
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-14786000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-18526000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-128293000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-310014000
us-gaap Net Income Loss
NetIncomeLoss
-255431000
us-gaap Net Income Loss
NetIncomeLoss
-348135000
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.52
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.52
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.07
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.07
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-3.14
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-3.14
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-2.5
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-2.5
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.04
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.04
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-2.26
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-2.26
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.06
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.06
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-2.99
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-2.99
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.33
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.08
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.49
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86827991
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
86827991
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71629443
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71629443
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83056230
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
83056230
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63383000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63383000
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-131550000
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-148162000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-260741000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-158731000
CY2023Q3 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
-26648000
us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
-12470000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5516000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2369000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4748000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9529000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5516000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-29017000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4748000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21999000
CY2024Q3 cgc Comprehensive Income Loss Net Of Tax From Continuing Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-126034000
CY2023Q3 cgc Comprehensive Income Loss Net Of Tax From Continuing Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-177179000
cgc Comprehensive Income Loss Net Of Tax From Continuing Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-255993000
cgc Comprehensive Income Loss Net Of Tax From Continuing Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-180730000
CY2024Q3 cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
3257000
CY2023Q3 cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
-176638000
cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
5310000
cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
-207930000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-122777000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-353817000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-250683000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-388660000
CY2023Q3 cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Attributable To Noncontrolling Interests And Redeemable Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsAttributableToNoncontrollingInterestsAndRedeemableNoncontrollingInterest
-14786000
cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Attributable To Noncontrolling Interests And Redeemable Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsAttributableToNoncontrollingInterestsAndRedeemableNoncontrollingInterest
-18526000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-122777000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-339031000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-250683000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-370134000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
500507000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46291000
CY2024Q2 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Share Issue Costs
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndShareIssueCosts
-3189000
CY2024Q2 cgc Exercise Of Warrants
ExerciseOfWarrants
7563000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4151000
CY2024Q2 cgc Adjustments To Additional Paid In Capital Extinguishment Of Promissory Note And Issuance Of Exchangeable Shares
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfPromissoryNoteAndIssuanceOfExchangeableShares
74098000
CY2024Q2 cgc Disposal Group Including Discontinued Operation Issuance Of Common Shares
DisposalGroupIncludingDiscontinuedOperationIssuanceOfCommonShares
22711000
CY2024Q2 cgc Warrant Value Issuance Of Warrants
WarrantValueIssuanceOfWarrants
8697000
CY2024Q2 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-127906000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
532923000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
92185000
CY2024Q3 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Share Issue Costs
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndShareIssueCosts
-1522000
CY2024Q3 cgc Exercise Of Warrants
ExerciseOfWarrants
891000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
112000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5221000
CY2024Q3 cgc Warrant Value Issuance Of Warrants
WarrantValueIssuanceOfWarrants
2635000
CY2024Q3 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-122777000
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
509668000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
760022000
CY2023Q2 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Warrants Value
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndWarrantsValue
118803000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3716000
CY2023Q2 cgc Stock Issued During Period Value Redemption Of Redeemable Noncontrolling Interest
StockIssuedDuringPeriodValueRedemptionOfRedeemableNoncontrollingInterest
-193000
CY2023Q2 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34843000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
847505000
CY2023Q3 cgc Adjustments To Additional Paid In Capital Private Placement Net Of Issuance Costs
AdjustmentsToAdditionalPaidInCapitalPrivatePlacementNetOfIssuanceCosts
31633000
CY2023Q3 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Warrants Value
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndWarrantsValue
145200000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2718000
CY2023Q3 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
68582000
CY2023Q3 cgc Stock Issued During Period Value Redemption Of Redeemable Noncontrolling Interest
StockIssuedDuringPeriodValueRedemptionOfRedeemableNoncontrollingInterest
7643000
CY2023Q3 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-353817000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
749464000
us-gaap Profit Loss
ProfitLoss
-255431000
us-gaap Profit Loss
ProfitLoss
-366661000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
5310000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-207930000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-260741000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-158731000
us-gaap Depreciation
Depreciation
10628000
us-gaap Depreciation
Depreciation
16568000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10709000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13073000
cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
9372000
cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
6434000
cgc Gain Loss On Asset Impairment And Restructuring
GainLossOnAssetImpairmentAndRestructuring
-18768000
cgc Gain Loss On Asset Impairment And Restructuring
GainLossOnAssetImpairmentAndRestructuring
25986000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6496000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14839000
cgc Non Cash Fair Value Adjustments And Charges Related To Settlement Of Long Term Debt
NonCashFairValueAdjustmentsAndChargesRelatedToSettlementOfLongTermDebt
147290000
cgc Non Cash Fair Value Adjustments And Charges Related To Settlement Of Long Term Debt
NonCashFairValueAdjustmentsAndChargesRelatedToSettlementOfLongTermDebt
44438000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3892000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12903000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11972000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4240000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5643000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
250000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-22000000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-13038000
cgc Increase Decrease In Other Non Cash Foreign Currency
IncreaseDecreaseInOtherNonCashForeignCurrency
12431000
cgc Increase Decrease In Other Non Cash Foreign Currency
IncreaseDecreaseInOtherNonCashForeignCurrency
52817000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-105632000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-172613000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-54709000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-105632000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-227322000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6509000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2636000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
803000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4932000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
152417000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-30184000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-81015000
cgc Payments For Proceeds From Divestiture Of Interest In Deconsolidation Of Subsidiaries And Affiliates
PaymentsForProceedsFromDivestitureOfInterestInDeconsolidationOfSubsidiariesAndAffiliates
6968000
us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
28303000
us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
831000
cgc Payments For Proceeds From Other Financial Assets
PaymentsForProceedsFromOtherFinancialAssets
95335000
cgc Payments For Proceeds From Other Financial Assets
PaymentsForProceedsFromOtherFinancialAssets
472000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10513000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-45407000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
219839000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
13414000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-17122000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31993000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
202717000
cgc Proceeds From Issuance Of Common Shares And Warrants
ProceedsFromIssuanceOfCommonSharesAndWarrants
138476000
cgc Proceeds From Issuance Of Common Shares And Warrants
ProceedsFromIssuanceOfCommonSharesAndWarrants
33795000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
112000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
8454000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
68255000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
13484000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
415185000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-7096000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-25908000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
194717000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-407298000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1024000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2129000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58116000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-434032000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
170300000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
677007000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
228416000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
242975000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
9314000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
2599000
cgc Income Taxes Received
IncomeTaxesReceived
77000
cgc Income Taxes Received
IncomeTaxesReceived
3344000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
4540000
us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
11285000
us-gaap Income Taxes Paid
IncomeTaxesPaid
258000
us-gaap Income Taxes Paid
IncomeTaxesPaid
1290000
us-gaap Interest Paid Net
InterestPaidNet
36014000
us-gaap Interest Paid Net
InterestPaidNet
58881000
cgc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-174000
cgc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-199000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.52%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates. Financial statement areas that require significant judgements and estimates are as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Allowance for credit losses </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">- The assessment involves judgement and incorporates estimates of loss based on available information relevant to considering the collectability and includes consideration of economic and business conditions, default trends and other internal and external factors. The amount is subject to change based on experience and new information which could result in outcomes that require adjustment to the carrying amounts affecting future periods.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventory reserves</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The Company records inventory reserves based on the Company’s estimated forecast of product demand, production requirements, market conditions and regulatory environment. Actual losses may differ from management’s estimates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Estimated useful lives, impairment considerations, and amortization of property, plant and equipment and intangible assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - Amortization of capital and intangible assets is dependent upon estimates of useful lives based on management’s judgment.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Goodwill and indefinite lived intangible asset impairment testing requires management to make estimates in the impairment testing model. On at least an annual basis, the Company tests whether goodwill and indefinite lived intangible assets are impaired. The reporting unit's fair value is determined using a discounted future cash flow model, which incorporate assumptions regarding future events, specifically future cash flows, growth rates and discount rates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Impairment of long-lived assets is influenced by judgment in defining an asset group and determining the indicators of impairment, and estimates used to measure impairment losses.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Legal proceedings</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - Judgement is used in determining the probability of incurring a loss in addition to determining the estimated amount. Amounts recorded are based on management’s judgement and actual amounts recorded may not be realized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair value measurement of financial instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The use of various valuation approaches described in Note 23 may involve uncertainties and determinations based on the Company’s judgment and any value estimated from these techniques may not be realized or realizable.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consolidation of variable interest entities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The determination of whether the Company is the primary beneficiary of a variable interest entity requires significant judgement. The assessment requires a qualitative analysis of power and benefits of the variable interest entity.</span></p>
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On December 13, 2023, the Company announced that the Company’s board of directors (the “Board”) had approved the consolidation of the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for every 10 pre-consolidation common shares (the “Share Consolidation”).
CY2022Q4 cgc Percentage Ownership Of Wholly Owned Subsidiaries
PercentageOwnershipOfWhollyOwnedSubsidiaries
1
CY2024Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20830000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20850000
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
29895000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
27961000
CY2024Q3 us-gaap Cash
Cash
142301000
CY2024Q1 us-gaap Cash
Cash
115427000
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
86115000
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
54873000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
228416000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170300000
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
2805000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
33161000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2805000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
33161000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36515000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44943000
CY2024Q3 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
1597000
CY2024Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
2517000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
2371000
CY2024Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
876000
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1377000
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3511000
CY2024Q3 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
41860000
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
51847000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13005000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9903000
CY2024Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
17113000
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
18872000
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
40930000
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
31367000
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
32051000
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27053000
CY2024Q3 us-gaap Inventory Net
InventoryNet
90094000
CY2024Q1 us-gaap Inventory Net
InventoryNet
77292000
CY2024Q3 us-gaap Inventory Write Down
InventoryWriteDown
1215000
us-gaap Inventory Write Down
InventoryWriteDown
1905000
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
3958000
us-gaap Inventory Write Down
InventoryWriteDown
7503000
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11935000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6621000
CY2024Q3 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
4714000
CY2024Q1 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
2365000
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
4351000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
14246000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21000000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23232000
CY2024Q1 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
437629000
cgc Other Financial Assets Additions
OtherFinancialAssetsAdditions
308459000
cgc Changes In Other Financial Asset Fair Value Through Profit Or Loss
ChangesInOtherFinancialAssetFairValueThroughProfitOrLoss
-46619000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
861000
cgc Other Financial Assets Other
OtherFinancialAssetsOther
458185000
CY2024Q3 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
242145000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
407691000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
418283000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
104526000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
98180000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303165000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320103000
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
202201000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
65913000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
199588000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
75453000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
95386000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
104053000
CY2023Q1 us-gaap Goodwill
Goodwill
85563000
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
42081000
CY2024 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-243000
CY2024Q1 us-gaap Goodwill
Goodwill
43239000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1292000
CY2024Q3 us-gaap Goodwill
Goodwill
44531000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11931000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21468000
CY2024Q3 cgc Taxes And Government Fees Payable Current
TaxesAndGovernmentFeesPayableCurrent
10917000
CY2024Q1 cgc Taxes And Government Fees Payable Current
TaxesAndGovernmentFeesPayableCurrent
10519000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3584000
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5849000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16304000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16203000
CY2024Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
42736000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
54039000
CY2024Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
707000
CY2024Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
1143000
CY2024Q3 us-gaap Senior Notes
SeniorNotes
553850000
CY2024Q1 us-gaap Senior Notes
SeniorNotes
597229000
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
137918000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
103935000
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
415932000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
493294000
CY2021Q1 cgc Debt Instrument Discounted Price
DebtInstrumentDiscountedPrice
930000
CY2018Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.06
CY2018Q4 cgc Proceeds From Credit Facility
ProceedsFromCreditFacility
100000000
CY2020Q3 cgc Cancellation Of Debt
CancellationOfDebt
63500000
CY2018Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-09-10
CY2018Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.85
CY2020Q3 cgc Accretion Rate
AccretionRate
0.1106
CY2023Q3 cgc Principal Amount Of Accretion Debentures
PrincipalAmountOfAccretionDebentures
10434000
CY2020Q3 cgc Debt Instrument Monthly Interest Rate Percentage
DebtInstrumentMonthlyInterestRatePercentage
0.01
CY2022Q2 cgc Debt Instrument Shares Acquired Percentage
DebtInstrumentSharesAcquiredPercentage
1
CY2020Q3 cgc Conversion Of Outstanding Debentures Description
ConversionOfOutstandingDebenturesDescription
In addition, the Company may force conversion of the Supreme Debentures outstanding with 30 days’ notice if the daily volume weighted average trading price of the Company’s common shares is greater than $385.90 for any 10 consecutive trading days. The Company, Supreme Cannabis and the Trustee entered into a further supplemental indenture whereby the Company agreed to guarantee the obligations of Supreme Cannabis pursuant to the Supreme Debentures and the Accretion Debentures.
CY2024Q3 cgc Principal Payments Of Accretion Debentures
PrincipalPaymentsOfAccretionDebentures
0
cgc Principal Payments Of Accretion Debentures
PrincipalPaymentsOfAccretionDebentures
677000
CY2024Q3 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
42117000
CY2024Q3 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
17553000
CY2024Q3 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
59670000
CY2024Q1 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
15173000
CY2024Q1 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
55597000
CY2024Q1 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
70770000
CY2024Q3 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
26755000
CY2024Q3 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
4242000
CY2024Q3 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
30997000
CY2024Q1 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
12809000
CY2024Q1 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
10558000
CY2024Q1 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
23367000
CY2024Q3 cgc Refund Liability Current
RefundLiabilityCurrent
4206000
CY2024Q3 cgc Refund Liability
RefundLiability
4206000
CY2024Q1 cgc Refund Liability Current
RefundLiabilityCurrent
4169000
CY2024Q1 cgc Refund Liability
RefundLiability
4169000
CY2024Q3 cgc Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
9188000
CY2024Q3 cgc Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
3669000
CY2024Q3 cgc Settlement Liabilities And Other
SettlementLiabilitiesAndOther
12857000
CY2024Q1 cgc Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
15917000
CY2024Q1 cgc Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
5659000
CY2024Q1 cgc Settlement Liabilities And Other
SettlementLiabilitiesAndOther
21576000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
82266000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25464000
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
107730000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48068000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
71814000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
119882000
CY2023Q3 cgc Number Of Equity Financing
NumberOfEquityFinancing
0
CY2023Q3 cgc Number Of Equity Financing
NumberOfEquityFinancing
0
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10451457
CY2024Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
9.12
CY2024Q1 cgc Warrant Value
WarrantValue
2610519000
cgc Number Of Whole Warrants On Issuance Of Warrants
NumberOfWholeWarrantsOnIssuanceOfWarrants
3350430
cgc Average Exercise Price On Issuance Of Warrants
AverageExercisePriceOnIssuanceOfWarrants
16.18
cgc Warrant Value Issuance Of Warrants
WarrantValueIssuanceOfWarrants
8697000
cgc Number Of Whole Warrants On Exercise Of Warrants
NumberOfWholeWarrantsOnExerciseOfWarrants
1279660
cgc Average Exercise Price On Warrant Exercised
AverageExercisePriceOnWarrantExercised
6.6
cgc Warrant Value Exercise Of Warrants
WarrantValueExerciseOfWarrants
-3018000
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12522227
CY2024Q3 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
11.26
CY2024Q3 cgc Warrant Value
WarrantValue
2616198000
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12819305
CY2023Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
580.4
CY2023Q1 cgc Warrant Value
WarrantValue
2581788000
cgc Number Of Whole Warrants On Issuance Of Warrants From Private Placement
NumberOfWholeWarrantsOnIssuanceOfWarrantsFromPrivatePlacement
2292947
cgc Average Exercise Price On Issuance Of Warrants From Private Placement
AverageExercisePriceOnIssuanceOfWarrantsFromPrivatePlacement
18.33
cgc Warrant Value Issuance Of Warrants From Private Placement
WarrantValueIssuanceOfWarrantsFromPrivatePlacement
8977000
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
15112252
CY2023Q3 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
495.1
CY2023Q3 cgc Warrant Value
WarrantValue
2590765000
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1281815
CY2023Q3 cgc Extended Period Of Option From Grant Date
ExtendedPeriodOfOptionFromGrantDate
P10Y
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2883922
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.01
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
765107
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.37
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18347
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.13
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
162827
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
319.28
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3467855
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.46
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3467855
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M19D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1087789
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M24D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
45.46
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
98.51
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.01
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
312.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.16
cgc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.17
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62991000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69595000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129203000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145853000
CY2024Q3 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
1300000
cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
2500000
CY2023Q3 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
570000
cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
1507000
CY2024Q3 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
4206000
CY2024Q1 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
4169000
CY2024Q3 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
47432000
CY2023Q3 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
82306000
cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
46619000
cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
17188000
CY2024Q3 cgc Equity Method Investments Fair Value Adjustment
EquityMethodInvestmentsFairValueAdjustment
-13668000
cgc Equity Method Investments Fair Value Adjustment
EquityMethodInvestmentsFairValueAdjustment
-89638000
CY2023Q3 cgc Debt Fair Value Adjustment
DebtFairValueAdjustment
-27066000
cgc Debt Fair Value Adjustment
DebtFairValueAdjustment
-25214000
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
6717000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3741000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
33472000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-10517000
CY2024Q3 cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
320000
CY2023Q3 cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
-7262000
cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
22439000
cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
-12553000
CY2024Q3 cgc Interest Income
InterestIncome
2416000
CY2023Q3 cgc Interest Income
InterestIncome
3454000
cgc Interest Income
InterestIncome
4474000
cgc Interest Income
InterestIncome
11285000
CY2024Q3 us-gaap Interest Expense
InterestExpense
21278000
CY2023Q3 us-gaap Interest Expense
InterestExpense
27415000
us-gaap Interest Expense
InterestExpense
42421000
us-gaap Interest Expense
InterestExpense
59600000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
674000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4737000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
707000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
4598000
CY2024Q3 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
380000
CY2023Q3 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
3783000
cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
5336000
cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
5922000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-85305000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-128334000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-179194000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-82233000
CY2024Q3 cgc Debentures Bear Interest Rate Per Annum
DebenturesBearInterestRatePerAnnum
0.061
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62991000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69595000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129203000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145853000
CY2024Q3 us-gaap Gross Profit
GrossProfit
21838000
CY2023Q3 us-gaap Gross Profit
GrossProfit
23426000
us-gaap Gross Profit
GrossProfit
44869000
us-gaap Gross Profit
GrossProfit
37188000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
41730000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
57611000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
89698000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
120374000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5221000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2717000
us-gaap Share Based Compensation
ShareBasedCompensation
9372000
us-gaap Share Based Compensation
ShareBasedCompensation
6434000
CY2024Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20830000
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
29895000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20850000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
27961000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-45943000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7007000
us-gaap Operating Income Loss
OperatingIncomeLoss
-75051000
us-gaap Operating Income Loss
OperatingIncomeLoss
-61659000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-85305000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-128334000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-179194000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-82233000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-131248000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-135341000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-254245000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-143892000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62991000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
69595000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
129203000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
145853000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
303165000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320103000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-123672-index-headers.html Edgar Link pending
0000950170-24-123672-index.html Edgar Link pending
0000950170-24-123672.txt Edgar Link pending
0000950170-24-123672-xbrl.zip Edgar Link pending
cgc-20240930.htm Edgar Link pending
cgc-20240930.xsd Edgar Link pending
cgc-ex31_1.htm Edgar Link pending
cgc-ex31_2.htm Edgar Link pending
cgc-ex32_1.htm Edgar Link pending
cgc-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
cgc-20240930_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable